Clinical Trials Directory

Trials / Completed

CompletedNCT05709002

Smoking, Stress, HIV and Mobile Technology

A Fully Automated and Culturally-Adapted mHealth Intervention for Smoking Cessation Among Black Smokers With HIV

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
University of Houston · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The present investigation aims to address disparities in cigarette use outcomes among Black/African American adults with HIV. The specific aims of this study are: (1) To modify a recently developed, culturally adapted, mobile application for Black smokers by integrating information specifically relevant to Black persons with HIV/AIDS. (2) To conduct a randomized clinical trial for anxiety-sensitivity reduction and cigarette cessation among Black smokers with HIV.

Detailed description

The current trial aims to refine and conduct a comprehensive cultural and HIV-sensitive adaptation of an initially tested, novel mobile intervention (MASP+) targeting anxiety sensitivity (AS) among Black/African American (daily) cigarette users with HIV/AIDS. The MASP+ app prompts users remotely throughout the day to assess mood symptoms, cigarette cravings or nicotine withdrawal symptoms, and general mental health. When respondents indicate they are struggling with cigarette urges or cravings, or if they are experiencing heightened levels of stress or anxiety, the app selects and delivers a tailored message from a library of messages and videos. The MASP+ app has the potential to deliver highly effective and accessible treatment to a highly underserved subpopulation within the Black community considered to be at exceptionally high risk of smoking problems (social, psychological, physical) and smoking relapse.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMASP+mHealth (mobile app) for smoking cessation
BEHAVIORALControlA mobile app designed to assist the general population with smoking cessation.

Timeline

Start date
2023-10-16
Primary completion
2025-06-24
Completion
2025-06-24
First posted
2023-02-01
Last updated
2025-07-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05709002. Inclusion in this directory is not an endorsement.